Form D — Ensho Therapeutics, Inc.
0002032849-26-000002 · filed Oct 15, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $15,604,179
- Total sold
- $7,281,948
- Minimum investment
- $1
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ensho Therapeutics, Inc.
- CIK
- 2032849
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 50 Tice Boulevard
Woodcliff Lake, NJ 07677 - Phone
- 973-475-8970
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Danielle Fry · Executive OfficerWoodcliff Lake, NJ Find on LinkedIn ↗
-
Arash Rassoulpour · DirectorWoodcliff Lake, NJ Find on LinkedIn ↗
-
Carlos Solorzano · DirectorWoodcliff Lake, NJ Find on LinkedIn ↗
-
Eric Pham · DirectorWoodcliff Lake, NJ Find on LinkedIn ↗
-
Gerhard Hagn · DirectorWoodcliff Lake, NJ Find on LinkedIn ↗
-
Neena Bitritto-Garg · DirectorWoodcliff Lake, NJ Find on LinkedIn ↗
-
Tariq Kassum · DirectorWoodcliff Lake, NJ Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗